Innovative Treatment for Osteoarthritis Using Menstrual Blood
It’s quite an unexpected breakthrough. A recent study has unveiled a unique method to possibly help the over 600 million people affected by osteoarthritis.
While menstrual blood is often seen as just a nuisance for many women, it appears there are potential upsides to those monthly cycles.
The researchers from Lithuania explored using extracellular vesicles from menstrual blood. These tiny particles, released by cells, could aid in tissue regeneration and inflammation reduction, potentially playing a role in cartilage repair.
The team tested these particles on post-surgery tissue samples from ten female donors with osteoarthritis, aiming to evaluate their effects.
Still, more work is needed to enhance the longevity of these vesicles and optimize treatment results. This is where the research gets interesting: they introduced a biological scaffold. This helps shield the extracellular vesicles from menstrual blood cells while slowly releasing them during joint movements.
Interestingly, the menstrual cells not only enhanced the function of chondrocytes but also helped slow down tissue degradation. They even promoted an increase in progesterone receptor levels in older chondrocytes.
Most current osteoarthritis treatments mainly focus on pain relief and inflammation management, rather than halting or reversing cartilage damage. This new approach, remarkably, might make it possible to regenerate cartilage—without the invasive procedures typically associated with bone marrow harvesting.
As degenerative conditions become more prevalent with age, alongside rising obesity and injury rates, regenerative medicine may become a key player in future treatments.
It’s worth noting that some other experimental methods, like radiation, may reduce pain, but they do nothing to tackle the root cause of cartilage loss.
However, a few hurdles remain before this innovative treatment can be fully realized. Edvinus Krugley, a senior researcher at KTU’s Faculty of Chemical Technology, highlighted a significant challenge. “Creating effective biomimetic scaffolds requires the material to perform well in multiple areas simultaneously,” he mentioned in a press release. “It needs to be chemically stable, mechanically strong, biologically suitable, and feasible to produce.”
“With cartilage, it’s especially tricky since we need to replicate both its natural structure and its ability to withstand mechanical stress,” he added.
